MIGDEN, M.; LEAR, J.; SQUITTIERI, N.; LIU, L.; GUMINSKI, A.; DUMMER, R. Duration of Response and Progression-Free Survival with Sonidegib 200 Mg Once Daily Until Disease Progression or Start of New Antineoplastic Therapy in Patients with Locally Advanced Basal Cell Carcinoma: Results of the 42-Month, Randomized, Double-Blind. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 4, n. 5, p. s68, 2020. DOI: 10.25251/skin.4.supp.67. Disponível em: https://www.jofskin.org/index.php/skin/article/view/1017. Acesso em: 1 jul. 2022.